etcembly | news

Oct 2

Etcembly launches groundbreaking research study searching for cancer cures in survivors

Oxford, UK - British techbio innovator Etcembly has launched a groundbreaking new research study aiming to uncover new targets for...

28 views

Aug 23

Etcembly have been picked by Oliver Sims of Octopus Ventures as one of the top 13 techbio companies to watch.

Read the full story about top techbio companies here:

52 views

Aug 12

Etcembly launching groundbreaking study to uncover whether cancer survivors hold the key to new cures

332 views

Dec 2, 2023

Etcembly featured in BIA TechBio 2023 report

Etcembly are showcased as one of the companies driving the UK's AI revolution. https://techbio.org.uk/wp-content/uploads/2023/10/TechBio-...

106 views

Dec 2, 2023

Could AI cure cancer?

Marc Emmer at Inc. highlights how our approach could accelerate the development of new imnmunotherapies. https://www.inc.com/marc-emmer/...

56 views

Dec 2, 2023

Supporting the next generation in biotech

Discover how we're enabling our former intern Gusztav Milotay to pursue a PhD at the University of Oxford.

34 views

Dec 2, 2023

Etcembly aims at cancer with AI-driven, rapid TCR engineering technology

Caroline Richards at BioWorld explores how our AI-driven approach is enabling TCR discovery and optimisation at unprecedented scale and...

42 views

Dec 2, 2023

Interview with CEO Michelle Teng in Inside Precision Medicine

Etcembly co-founder Michelle Teng talks to Helen Albert about her journey in science and how we're building the next generation of...

54 views

Sep 20, 2023

Etcembly's TCR therapeutics featured in Forbes

AI expert and futurist Bernard Marr has written about Etcembly's innovative generative AI approach to developing TCR-based cancer...

121 views

Aug 23, 2023

Etcembly reveals world’s first generative AI-designed T cell engager with picomolar affinity

Techbio innovator Etcembly reveals world’s first generative AI-designed bispecific T cell engager with picomolar affinity.

2,264 views